Hongkai Ji

Johns Hopkins University

Papers

1

Total Citations

50

H-Index

1

About

Hongkai Ji is a pioneering researcher in the fields of bioinformatics, genomics, and high-throughput screening technologies. His major contributions center on developing innovative computational and experimental platforms to decode gene regulation and accelerate drug discovery. Notably, Ji led the creation of ARQiv-HTS, a versatile whole-organism screening platform that enables in vivo drug discovery at high-throughput rates, a breakthrough that has garnered over 50 citations and opened new avenues for phenotypic drug screening. His work has significantly advanced our understanding of transcriptional regulatory networks, particularly through the integration of ChIP-seq, RNA-seq, and other genomic data. With a citation count that underscores his influence, Ji's research has provided critical tools for mapping enhancer-promoter interactions and identifying key transcription factors in development and disease. His achievements include developing algorithms for analyzing high-throughput sequencing data and contributing to large-scale genomics consortia. For students and researchers, Ji’s work exemplifies how combining computational rigor with experimental innovation can solve complex biological problems, making him a key figure in modern genomics and drug discovery.

Research Focus

Key Achievements

1
H-Index
1
Papers
50
Total Citations
50
Avg Citations/Paper
🏆 Most Cited Paper
ARQiv-HTS, a versatile whole-organism screening platform enabling in vivo drug discovery at high-throughput rates
50 citations · 2016
📈 Most Prolific Year: 2016 (1 Papers)
🤝 Key Collaborators: 10
🏛 Institutions: Johns Hopkins University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago